Erratum: Cost-related motivated for conducting research: Participation should be informed (JAMA (2014) 311, 15, (1491-1492) DOI: 10.1001/jama.2014.1821);Cost-related motivations for conducting research: Participants should be informed

JAMA

Volumn 311, Issue 15, 2014, Pages 1491-1492

  Nayak, Rahul K ^a   Pearson, Steven D ^a,b   Miller, Franklin G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

CLINICAL RESEARCH; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG APPROVAL; DRUG COST; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; NOTE; OFF LABEL DRUG USE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH ETHICS; RESEARCH SUBJECT;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MACULAR DEGENERATION; MALE;

EID: 84898637588     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.10675     Document Type: Erratum

References (8)

1. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ; CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364(20):1897-1908.
2. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113(3):363-372, e5.
3. Office of Inspector General. Review of Medicare Part B Avastin and Lucentis treatments for age-related macular degeneration.Washington, DC: US Dept of Health and Human Services; 2011. Report A-01-10-00514.
4. Martin DF, Maguire MG, Fine SL. Identifying and eliminating the roadblocks to comparative-effectiveness research. N Engl J Med. 2010;363(2):105-107.
5. Comparison of age-related macular degeneration treatments trials. Lucentis-Avastin trial manual of procedures. 2011. http://www.med.upenn.edu/ cpob/studies/documents/CATTManualofProceduresJan2011.pdf. Accessed February 5, 2014.
6. Levine RJ. Ethics and Regulation of Clinical Research. 2nd ed. New Haven, CT: Yale University Press; 1988:100.
7. Protection of Human Subjects, 45 CFR part 46.116[a][1]. 2009. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. Accessed February 5, 2014.
8. Levine RJ. Consent Issues in Human Research. In: Emanuel EJ, Crouch RA, Arras JD, Moreno JD, Grady C, eds. Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary. Baltimore, MD: Johns Hopkins University Press; 2003:197-201.